Quantcast
Last updated on April 19, 2014 at 13:20 EDT

Latest Kymab Limited. Stories

2013-10-09 12:26:32

CAMBRIDGE, England, October 9, 2013 /PRNewswire/ -- Kymab, a monoclonal antibody biopharmaceutical company, announces today it has notified the English Court that it will defend the UK patent proceedings brought by Regeneron in respect of European patent EP1360287. Regeneron initiated these proceedings in September 2013. Kymab will defend the UK patent action on the grounds of non-infringement and invalidity of the patent. Earlier, in June 2013, Kymab opposed the...

2013-04-22 04:21:10

CAMBRIDGE, England, April 22, 2013 /PRNewswire/ -- Kymab, a monoclonal antibody biopharmaceutical company, announced today an agreement in therapeutic antibody discovery. Novo Nordisk has been granted a non-exclusive licence to Kymab's proprietary Kymouse(TM) human antibody discovery platform to discover, develop and commercialise therapeutic monoclonal antibody drugs for human diseases. The licence provides Novo Nordisk with access to the Kymouse HK and Kymouse HL...

2012-09-17 22:21:14

CAMBRIDGE, England, September 18, 2012 /PRNewswire/ -- First human antibody strain from its advanced discovery platform Kymab, a monoclonal antibody biopharmaceutical company, announced today the launch of Kymouse HK, the first strain from the innovative Kymouse(TM) antibody discovery platform, which enables rapid discovery of high affinity antibody drug candidates. Kymouse HK is a transgenic mouse that has been designed to produce a diverse repertoire...